-
Sodium Orthovanadate for Signaling Assays
2026-08-20
Sodium Orthovanadate helps preserve phosphorylation-dependent signals in adipocyte lysates, kinase assays, and enzyme workflows. This guide combines practical Na3VO4 handling with assay-specific controls inspired by research on PI3K/AKT/GLUT4 insulin signaling.
-
Gamma-linolenic acid: Workflow & Applications
2026-08-19
Gamma-linolenic acid (GLA) supports reproducible studies of LTB4-linked inflammation, lipid signaling, and cell death. This practical guide combines receptor, cell-based, and translational workflows with resistance-surveillance lessons from a psychiatric hospital study.
-
HDAC Inhibition Reverses EBV-Driven NPC Plasticity
2026-08-19
The reference study identifies an epigenetic mechanism through which EBV protein LMP1 drives dedifferentiation and stem-like plasticity in nasopharyngeal carcinoma. It shows that HDAC inhibition can restore CEBPA expression and partially reverse this state in cellular and mouse xenograft models, supporting differentiation-based cancer therapy for selected solid tumors.
-
LNP Self-Replicating RNA Vaccine Storage: Key Evidence
2026-08-18
The reference study systematically examines how temperature, buffer composition, cryoprotection, and lyophilization affect lipid nanoparticle-formulated self-replicating RNA vaccines. Its central practical finding is that RNAse-free PBS containing 10% sucrose supported preservation of structure and in vivo potency at −20°C for 30 days, while lyophilization also retained bioactivity under the tested conditions.
-
Anti-Diabetic Drugs and Fracture Risk: Network Evidence
2026-08-18
This systematic review and network meta-analysis integrated randomized evidence on fracture outcomes across multiple anti-diabetic therapies in type 2 diabetes. Its main contribution is a drug-specific comparison showing statistically significant signals for trelagliptin, albiglutide, and voglibose, while most other agents—including ertugliflozin—remained statistically comparable with placebo.
-
IDO1 Inhibition Activates Tumor-Protective STAT3
2026-08-17
The reference study shows that apo-IDO1 inhibition can activate immune cells while simultaneously inducing an IL-6–JAK2/STAT3 survival program within tumor cells. Its single-cell and mechanistic analyses support combining IDO1-directed treatment with pathway-level inhibition to limit this adaptive, tumor-protective response.
-
Paclitaxel (Taxol) Workflows for Cancer Research
2026-08-17
Translate Paclitaxel’s microtubule-stabilizing activity into reproducible cell-cycle, cytotoxicity, and targeted nanomedicine assays. This guide connects free-drug experiments with the carrier-free PTX/GA@FA-HSA strategy reported for triple-negative breast cancer, while emphasizing dosing controls and troubleshooting.
-
Paroxetine Mesylate: Applied Research Workflows
2026-08-16
Paroxetine Mesylate supports controlled SERT, CYP, kinase, and translational oncology experiments rather than serving only as an SSRI reference compound. This guide presents assay-ready workflows, quantitative starting points, cross-domain interpretation, and troubleshooting strategies for reproducible research.
-
SMPD4, Ceramide, and Primary Cilia in Brain Development
2026-08-15
A 2024 Development study connects SMPD4-dependent ceramide production with neural progenitor survival, Purkinje cell development, cerebellar architecture, and primary cilium maintenance. By integrating a mouse model with SMPD4-deficient human induced pluripotent stem cell systems and a ceramide-rescue experiment, the work provides mechanistic insight into microcephaly and cerebellar hypoplasia.
-
Monomethyl auristatin E (MMAE) in ADC Research
2026-08-14
Monomethyl auristatin E (MMAE) is a highly potent tubulin polymerization inhibitor used as an antibody-drug conjugate payload. Its value in cancer therapy comes from coupling auristatin cytotoxicity to antibody-mediated delivery, while its standalone form is not tumor-selective.
-
Dihydroethidium in Ultrasound Redox Assays
2026-08-14
Dihydroethidium, also known as hydroethidine, offers a practical route to monitor superoxide-associated red fluorescence in living cells. This guide connects DHE assay design with ultrasound-activated nanoparticle therapy, clarifying what the signal can—and cannot—prove about ROS, peroxynitrite, and apoptosis.
-
Angiotensin (1-7): Assay Workflow & Uses
2026-08-13
Build more reproducible Mas-receptor experiments with Angiotensin (1-7), from renal epithelial signaling to peptide-degradation assays involving periodontal pathogens. This guide combines literature-backed concentrations and dosing ranges with practical controls for peptide handling, pathway validation, and troubleshooting.
-
Neuroligin 1 Proteolysis Sustains Social Memory
2026-08-13
Liu and colleagues show that social interaction triggers secretase-dependent cleavage of Neuroligin 1 in the ventral hippocampus, producing an intracellular fragment that supports synaptic remodeling and social memory maintenance. The study combines molecular, genetic, pharmacological, behavioral, and spine analyses to establish NLG1-CTD and its PDZ-binding domain as a mechanistic link between social experience and persistent hippocampal plasticity.
-
Tetraethylammonium Chloride in K+ Channel Workflows
2026-08-12
Tetraethylammonium chloride gives researchers a practical pore-blocking perturbation for connecting K+ channel activity with secretion, vascular tone, and ion conduction. This guide translates a landmark β-cell study into reproducible TEAC workflows, control strategies, and troubleshooting decisions.
-
Neticonazole Hydrochloride: Evidence to Assay
2026-08-12
Neticonazole Hydrochloride is examined here through an evidence-weighted framework linking cutaneous candidiasis diagnosis with disciplined preclinical colorectal cancer research. The article translates clinical microscopy principles, compound handling data, and mechanistic hypotheses into practical assay decisions without overstating oncology maturity.